4.5 Article

International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010

期刊

JOURNAL OF HEART AND LUNG TRANSPLANTATION
卷 29, 期 7, 页码 717-727

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.healun.2010.05.017

关键词

cardiac allograft vasculopathy; angiography; intravascular ultrasound; cardiac allograft function; restrictive physiology; biomarkers; pediatric considerations

资金

  1. Astellas
  2. Roche
  3. Novartis
  4. Laboratorios Menarini

向作者/读者索取更多资源

The development of cardiac allograft vasculopathy remains the Achilles heel of cardiac transplantation. Unfortunately, the definitions of cardiac allograft vasculopathy are diverse, and there are no uniform international standards for the nomenclature of this entity. This consensus document, commissioned by the International Society of Heart and Lung Transplantation Board, is based on best evidence and clinical consensus derived from critical analysis of available information pertaining to angiography, intravascular ultrasound imaging, microvascular function, cardiac allograft histology, circulating immune markers, non-invasive imaging tests, and gene-based and protein-based biomarkers. This document represents a working formulation for an international nomenclature of cardiac allograft vasculopathy, similar to the development of the system for adjudication of cardiac allograft rejection by histology. J Heart Lung Transplant 2010;29:717-27 (C) 2010 International Society for Heart and Lung Transplantation. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据